CLVS1_RAT
ID CLVS1_RAT Reviewed; 354 AA.
AC A6JFQ6;
DT 15-DEC-2009, integrated into UniProtKB/Swiss-Prot.
DT 15-DEC-2009, sequence version 1.
DT 03-AUG-2022, entry version 56.
DE RecName: Full=Clavesin-1 {ECO:0000303|PubMed:19651769};
DE AltName: Full=Retinaldehyde-binding protein 1-like 1;
GN Name=Clvs1 {ECO:0000303|PubMed:19651769};
GN Synonyms=Rlbp1l1 {ECO:0000250|UniProtKB:Q8IUQ0};
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1] {ECO:0000305}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN [2] {ECO:0000305}
RP FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX PubMed=19651769; DOI=10.1074/jbc.m109.034884;
RA Katoh Y., Ritter B., Gaffry T., Blondeau F., Honing S., McPherson P.S.;
RT "The clavesin family: neuron-specific lipid- and clathrin-binding Sec14
RT proteins regulating lysosomal morphology.";
RL J. Biol. Chem. 284:27646-27654(2009).
CC -!- FUNCTION: Required for normal morphology of late endosomes and/or
CC lysosomes in neurons. Binds phosphatidylinositol 3,5-bisphosphate
CC (PtdIns(3,5)P2). {ECO:0000250|UniProtKB:Q8IUQ0,
CC ECO:0000269|PubMed:19651769}.
CC -!- SUBUNIT: Forms a complex with clathrin heavy chain and gamma-adaptin.
CC {ECO:0000250|UniProtKB:Q8IUQ0}.
CC -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane
CC {ECO:0000269|PubMed:19651769}; Peripheral membrane protein
CC {ECO:0000269|PubMed:19651769}. Early endosome membrane
CC {ECO:0000250|UniProtKB:Q8IUQ0}; Peripheral membrane protein
CC {ECO:0000250|UniProtKB:Q8IUQ0}. Cytoplasmic vesicle, clathrin-coated
CC vesicle {ECO:0000269|PubMed:19651769}.
CC -!- TISSUE SPECIFICITY: Expressed in brain with no expression detected in
CC non-neuronal tissues (at protein level). {ECO:0000269|PubMed:19651769}.
CC -!- DOMAIN: The CRAL-TRIO domain is required for targeting to the membrane
CC and for binding PtdIns(3,5)P2. {ECO:0000250|UniProtKB:Q8IUQ0}.
CC -!- MISCELLANEOUS: Binding to PtdIns(3,5)P2 is not required for
CC localization. {ECO:0000250|UniProtKB:Q8IUQ0}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CH473984; EDM11652.1; -; Genomic_DNA.
DR RefSeq; NP_001102439.1; NM_001108969.1.
DR AlphaFoldDB; A6JFQ6; -.
DR SMR; A6JFQ6; -.
DR STRING; 10116.ENSRNOP00000009744; -.
DR PaxDb; A6JFQ6; -.
DR PeptideAtlas; A6JFQ6; -.
DR PRIDE; A6JFQ6; -.
DR Ensembl; ENSRNOT00000009744; ENSRNOP00000009744; ENSRNOG00000006919.
DR GeneID; 366311; -.
DR KEGG; rno:366311; -.
DR UCSC; RGD:1564200; rat.
DR CTD; 157807; -.
DR RGD; 1564200; Clvs1.
DR eggNOG; KOG1471; Eukaryota.
DR InParanoid; A6JFQ6; -.
DR OrthoDB; 1182715at2759; -.
DR PhylomeDB; A6JFQ6; -.
DR Reactome; R-RNO-432720; Lysosome Vesicle Biogenesis.
DR PRO; PR:A6JFQ6; -.
DR Proteomes; UP000002494; Chromosome 5.
DR Proteomes; UP000234681; Chromosome 5.
DR GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR GO; GO:1902936; F:phosphatidylinositol bisphosphate binding; IBA:GO_Central.
DR GO; GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; ISS:UniProtKB.
DR GO; GO:0007040; P:lysosome organization; IMP:UniProtKB.
DR CDD; cd00170; SEC14; 1.
DR Gene3D; 3.40.525.10; -; 1.
DR InterPro; IPR028634; Clavesin-1.
DR InterPro; IPR001251; CRAL-TRIO_dom.
DR InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR InterPro; IPR011074; CRAL/TRIO_N_dom.
DR InterPro; IPR036273; CRAL/TRIO_N_dom_sf.
DR PANTHER; PTHR10174:SF72; PTHR10174:SF72; 1.
DR Pfam; PF00650; CRAL_TRIO; 1.
DR Pfam; PF03765; CRAL_TRIO_N; 1.
DR SMART; SM01100; CRAL_TRIO_N; 1.
DR SMART; SM00516; SEC14; 1.
DR SUPFAM; SSF46938; SSF46938; 1.
DR SUPFAM; SSF52087; SSF52087; 1.
DR PROSITE; PS50191; CRAL_TRIO; 1.
PE 1: Evidence at protein level;
KW Cytoplasmic vesicle; Endosome; Golgi apparatus; Lipid-binding; Membrane;
KW Reference proteome.
FT CHAIN 1..354
FT /note="Clavesin-1"
FT /id="PRO_0000389619"
FT DOMAIN 118..279
FT /note="CRAL-TRIO"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00056"
FT REGION 317..354
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 354 AA; 40667 MW; C4A8C46E62368ACC CRC64;
MGPVSVLPKP QSISTWEGDL AKMTHLQAGL SPDTIEKARL ELNENPDVLH QDIQQVRDMI
ITRPDIGFLR TDDAFILRFL RARKFHQADA FRLLAQYFQY RQLNLDMFKN FKADDPGIKR
ALIDGFPGVL ENRDHYGRKI LLLFAANWDQ SRNSFTDILR AILLSLEVLI EDPELQINGF
ILIIDWSNFS FKQASKLTPS ILKLAIEGLQ DSFPARFGGV HFVNQPWYIH ALYTLIKPFL
KDKTRKRIFL HGNNLNSLHQ LIHPEFLPSE FGGTLPPYDM GTWARTLLGP DYSDENDYTH
TSYNAMYVKH TCSNLERECS PKPMKRSQSV VEAGTLKHEE KGENENTQPL LALD